Ultrasound helps deliver melasma treatment
Part of Skin clinical trials.
This trial tests a new way to deliver a medicine (tranexamic acid) into melasma patches using ultrasound waves. It aims to see if the ultrasound helps the medicine work better to lighten the dark spots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 55 years old.
- You have been diagnosed with melasma (dark patches on your face) by a doctor.
- You are not pregnant, nursing, or planning pregnancy during the trial.
- You have no known allergy to tranexamic acid.
- You have no history of blood clots or related conditions (like high blood pressure or high cholesterol).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a microneedling technique combined with three topical medications (metformin, tranexamic acid, and a modified Kligman's formula) to treat melasma, a common skin condition causing dark patches. The goal is to see if this approach safely and effectively reduces melasma in eligible women.
This study tests whether adding an oral medicine (tranexamic acid) to a standard triple cream works better for melasma than the cream alone. It may help lighten dark patches on your skin if you have the right type of melasma.
This study compares two oral treatments—melatonin and tranexamic acid—to see which works better for reducing melasma. Both are pills you take by mouth, and the goal is to find a safe, effective option for people with this skin condition.
This trial compares a new cosmetic serum to a standard treatment (4% hydroquinone) for facial melasma over 84 days. It may help if you have mild to moderate melasma and are looking for a gentler alternative.
This study tests whether a medicine called tranexamic acid, taken as a pill or used on the skin, can help fade melasma in women with darker skin types. It aims to find a safe way to improve skin color and is relevant to those looking for new melasma treatment options. The trial compares the treatment to another study treatment without medicine. Participation is open to women aged 30 to 60 with darker skin tones who are not pregnant and are not using certain other skin or hormone treatments.
This trial tests whether taking tranexamic acid (a medicine that helps reduce pigmentation) along with a skin treatment called microneedling is more effective for treating melasma than microneedling alone. It aims to help women with facial melasma achieve clearer, more even skin tone.
Hear when a new Melasma (Facial Melasma) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.